Oaktop Capital Management II Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AXDX
Accelerate Diagnostics
AXDX
|
+$1.68M |
| 2 |
ENOC
EnerNOC, Inc.
ENOC
|
+$657K |
| 3 |
RATE
Bankrate Inc
RATE
|
+$346K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$59.4M |
| 2 |
KLA
KLAC
|
+$29.2M |
| 3 |
CELG
Celgene Corp
CELG
|
+$310K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.08% |
| 2 | Technology | 23.41% |
| 3 | Financials | 4.61% |
| 4 | Communication Services | 2.78% |
| 5 | Industrials | 2.05% |
Similar funds
Oaktop Capital Management II's Q2 2016 Portfolio in Review
As of Q2 2016, Oaktop Capital Management II held 20 positions worth $412M, down 0.09% from $413M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Oaktop Capital Management II withdrew a net $56.8M in Q2 2016, closing 1 position and reducing 2 holdings. Its most notable exit was KLA, an estimated $29.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 52% a quarter earlier, followed by Technology and Financials.
Against the trend, Oaktop Capital Management II opened a new position in Accelerate Diagnostics worth $1.8M.
- Oaktop Capital Management II's largest Q2 2016 buy was Accelerate Diagnostics: 12,500 shares worth $1.8M.
- Oaktop Capital Management II added most to EnerNOC, Inc. in Q2 2016, an estimated $657K increase.
- Oaktop Capital Management II's biggest Q2 2016 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $59.4M.
- Oaktop Capital Management II fully exited KLA in Q2 2016, selling an estimated $29.2M.
- Oaktop Capital Management II's ten largest holdings make up 92% of its $412M portfolio in Q2 2016.
- Oaktop Capital Management II opened 2 new positions and closed 1 in Q2 2016.
- Oaktop Capital Management II's portfolio value fell 0.09% quarter-over-quarter to $412M.
Based on Oaktop Capital Management II's 13F filing for Q2 2016, filed 9 Aug 2016.